Galantamine increases excitability of CA1 hippocampal pyramidal neurons

Neuroscience

Volumn 137, Issue 1, 2006, Pages 113-123

  Oh, M M ^a   Wu, W W ^a   Power, J M ^a,b   Disterhoft, J F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Afterhyperpolarization; Aging; Alzheimer's disease; Cholinesterase inhibitor; Muscarinic; Nicotinic

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; ALPHA BUNGAROTOXIN; ATROPINE; GALANTAMINE; MUSCARINIC RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR BLOCKING AGENT;

ACTION POTENTIAL; AFTERHYPERPOLARIZATION; AGED; AGING; ALLOSTERISM; AMPLITUDE MODULATION; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HIPPOCAMPUS; INTRACELLULAR RECORDING; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RABBIT; SPIKE WAVE; STATISTICAL SIGNIFICANCE; TIME;

ACTION POTENTIALS; AGING; ANIMALS; ATROPINE; BUNGAROTOXINS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GALANTAMINE; HIPPOCAMPUS; MUSCARINIC ANTAGONISTS; NICOTINIC ANTAGONISTS; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RABBITS; RECEPTORS, MUSCARINIC; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION;

EID: 29744467225     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.08.063     Document Type: Article

References (63)

1. M. Alkondon, E.F. Pereira, C.T. Barbosa, E.X. Albuquerque Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices J Pharmacol Exp Ther 283 1997 1396 1411
2. A. Alvarez, R. Alarcon, C. Opazo, E.O. Campos, F.J. Munoz, F.H. Calderon, F. Dajas, M.K. Gentry, B.P. Doctor, F.G. De Mello, N.C. Inestrosa Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils J Neurosci 18 1998 3213 3223
3. D.M. Araujo, P.A. Lapchak, Y. Robitaille, S. Gauthier, R. Quirion Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease J Neurochem 50 1988 1914 1923
4. E. Arias, E. Ales, N.H. Gabilan, M.F. Cano-Abad, M. Villarroya, A.G. Garcia, M.G. Lopez Galantamine prevents apoptosis induced by β-amyloid and thapsigargin involvement of nicotinic acetylcholine receptors Neuropharmacology 46 2004 103 114
5. D.S. Auld, S. Kar, R. Quirion β-Amyloid peptides as direct cholinergic neuromodulators a missing link? Trends Neurosci 21 1998 43 49
6. N. Barazangi, L.W. Role Nicotine-induced enhancement of glutamatergic and GABAergic synaptic transmission in the mouse amygdala J Neurophysiol 86 2001 463 474
7. R.T. Bartus, R.L. Dean III, B. Beer, A.S. Lippa The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
8. L.S. Benardo, D.A. Prince Cholinergic excitation of mammalian hippocampal pyramidal cells Brain Res 249 1982 315 331
9. 2+ channel activity in single neurons of hippocampal "zipper" slices Proc Natl Acad Sci USA 97 2000 4357 4362
10. A.E. Cole, R.A. Nicoll Acetylcholine mediates a slow synaptic potential in hippocampal pyramidal cells Science 221 1983 1299 1301
11. D.A. Coulter, J.J. Lo Turco, M. Kubota, J.F. Disterhoft, J.W. Moore, D.L. Alkon Classical conditioning reduces amplitude and duration of calcium-dependent afterhyperpolarization in rabbit hippocampal pyramidal cells J Neurophysiol 61 1989 971 981
12. J. Court, C. Martin-Ruiz, M. Piggott, D. Spurden, M. Griffiths, E. Perry Nicotinic receptor abnormalities in Alzheimer's disease Biol Psychiatry 49 2001 175 184
13. J.L. Cummings, P.A. Cyrus, F. Bieber, J. Mas, J. Orazem, B. Gulanski Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group Neurology 50 1998 1214 1221
14. J.A. Dani Overview of nicotinic receptors and their roles in the central nervous system Biol Psychiatry 49 2001 166 174
15. J.F. Disterhoft, M.M. Oh Modulation of cholinergic transmission enhances excitability of hippocampal pyramidal neurons and ameliorates learning impairments in aging animals Neurobiol Learn Mem 80 2003 223 233
16. B. Fulton, P. Benfield Galanthamine Drugs Aging 9 1996 60 65
17. R. Gray, A.S. Rajan, K.A. Radcliffe, M. Yakehiro, J.A. Dani Hippocampal synaptic transmission enhanced by low concentrations of nicotine Nature 383 1996 713 716
18. S. Kar, A.M. Issa, D. Seto, D.S. Auld, B. Collier, R. Quirion Amyloid β-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices J Neurochem 70 1998 2179 2187
19. T. Kihara, S. Shimohama, M. Urushitani, H. Sawada, J. Kimura, T. Kume, T. Maeda, A. Akaike Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity Brain Res 792 1998 331 334
20. M.A. Kronforst-Collins, P.L. Moriearty, B. Schmidt, J.F. Disterhoft Metrifonate improves associative learning and retention in aging rabbits Behav Neurosci 111 1997 1031 1040
21. A. Kumar, T.C. Foster 17β-Estradiol benzoate decreases the AHP amplitude in CA1 pyramidal neurons J Neurophysiol 88 2002 621 626
22. B. Lancaster, P.R. Adams Calcium-dependent current generating the afterhyperpolarization of hippocampal neurons J Neurophysiol 55 1986 1268 1282
23. 2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats Science 226 1984 1089 1092
24. C. Lena, A. de Kerchove D'Eexaerde, M. Cordero-Erausquin, N. le Novere, M. Mar Arroyo-Jimenez, J.P. Changeux Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons Proc Natl Acad Sci USA 96 1999 12126 12131
25. Q. Liu, H. Kawai, D.K. Berg β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neurons Proc Natl Acad Sci USA 98 2001 4734 4739
26. E.D. London, M.J. Ball, S.B. Waller Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's dementia Neurochem Res 14 1989 745 750
27. A. Maelicke, M. Samochocki, R. Jostock, A. Fehrenbacher, J. Ludwig, E.X. Albuquerque, M. Zerlin Allosteric sensitization of nicotinic receptors by galantamine, a new treatment strategy for Alzheimer's disease Biol Psychiatry 49 2001 279 288
28. R.C. Malenka, R.A. Nicoll Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells Brain Res 379 1986 210 215
29. M.J. Marks, J.R. Pauly, S.D. Gross, E.S. Deneris, I. Hermans-Borgmeyer, S.F. Heinemann, A.C. Collins Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment J Neurosci 12 1992 2765 2784
30. J.R. Moyer, J.M. Power, L.T. Thompson, J.F. Disterhoft Increased excitability of aged rabbit CA1 neurons after trace eyeblink conditioning J Neurosci 20 2000 5476 5482
31. J.R. Moyer, L.T. Thompson, J.P. Black, J.F. Disterhoft Nimodipine increases excitability of rabbit CA1 pyramidal neurons in an age- and concentration-dependent manner J Neurophysiol 68 1992 2100 2109
32. J.R. Moyer, L.T. Thompson, J.F. Disterhoft Trace eyeblink conditioning increases CA1 excitability in a transient and learning-specific manner J Neurosci 16 1996 5536 5546
33. P.A. Newhouse, A. Potter, M. Kelton, J. Corwin Nicotinic treatment of Alzheimer's disease Biol Psychiatry 49 2001 268 278
34. M.M. Oh, A.G. Kuo, W.W. Wu, E.A. Sametsky, J.F. Disterhoft Watermaze learning enhances excitability of CA1 pyramidal neurons J Neurophysiol 90 2003 2171 2179
35. M.M. Oh, J.M. Power, L.T. Thompson, P.L. Moriearty, J.F. Disterhoft Metrifonate increases neuronal excitability in CA1 pyramidal neurons from both young and aging rabbit hippocampus J Neurosci 19 1999 1814 1823
36. M.M. Oh, W.W. Wu, R.W. Vogel, D.S. Woodruff-Pak, J.F. Disterhoft Galanthamine enhances CA1 neuronal excitability and facilitates learning in young and aging rabbits Soc Neurosci Abstr 26 2000 2014
37. M. Pakaski, Z. Rakonczay, P. Kasa Reversible and irreversible acetylcholinesterase inhibitors cause changes in neuronal amyloid precursor protein processing and protein kinase C level in vitro Neurochem Int 38 2001 219 226
38. Y.P. Pan, X.H. Xu, X.L. Wang Galantamine blocks delayed rectifier, but not transient outward potassium current in rat dissociated hippocampal pyramidal neurons Neurosci Lett 336 2003 37 40
39. D. Paterson, A. Nordberg Neuronal nicotinic receptors in the human brain Prog Neurobiol 61 2000 75 111
40. AHP via cyclic AMP-dependent protein kinase in hippocampal neurons J Neurophysiol 74 1995 2749 2753
41. 1-42 peptide directly modulates nicotinic receptors in the rat hippocampal slice J Neurosci 21 2001 RC120
42. B. Potier, O. Rascol, F. Jazat, Y. Lamour, P. Dutar Alterations in the properties of hippocampal pyramidal neurons in the aged rat Neuroscience 48 1992 793 806
43. M.A. Raskind, E.R. Peskind, T. Wessel, W. Yuan Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group Neurology 54 2000 2261 2268
44. A.H. Rezvani, E.D. Levin Cognitive effects of nicotine Biol Psychiatry 49 2001 258 267
45. D. Saar, Y. Grossman, E. Barkai Reduced after-hyperpolarization in rat piriform cortex pyramidal neurons is associated with increased learning capability during operant conditioning Eur J Neurosci 10 1998 1518 1523
46. M. Samochocki, M. Zerlin, R. Jostock, P.J. Groot Kormelink, W.H. Luyten, E.X. Albuquerque, A. Maelicke Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR Acta Neurol Scand Suppl 176 2000 68 73
47. M.D. Santos, M. Alkondon, E.F. Pereira, Y. Aracava, H.M. Eisenberg, A. Maelicke, E.X. Albuquerque The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system Mol Pharmacol 61 2002 1222 1234
48. 105-induced toxicity Biol Psychiatry 49 2001 240 247
49. S. Shimohama, T. Kihara Nicotinic receptor-mediated protection against β-amyloid neurotoxicity Biol Psychiatry 49 2001 233 239
50. B.B. Simon, B. Knuckley, D.A. Powell Galantamine facilitates acquisition of a trace-conditioned eyeblink response in healthy, young rabbits Learn Mem 11 2004 116 122
51. J.F. Storm Potassium currents in hippocampal pyramidal cells Prog Brain Res 83 1990 161 187
52. P.N. Tariot, P.R. Solomon, J.C. Morris, P. Kershaw, S. Lilienfeld, C. Ding A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group Neurology 54 2000 2269 2276
53. O. Thibault, P.W. Landfield Increase in single L-type calcium channels in hippocampal neurons during aging Science 272 1996 1017 1020
54. L.T. Thompson, J.R. Moyer, J.F. Disterhoft Transient changes in excitability of rabbit CA3 neurons with a time course appropriate to support memory consolidation J Neurophysiol 76 1996 1836 1849
55. G.C. Tombaugh, W.B. Rowe, G.M. Rose The slow afterhyperpolarization in hippocampal CA1 neurons covaries with spatial learning ability in aged Fisher 344 rats J Neurosci 25 2005 2609 2616
56. 2+ channels a possible involvement of free radicals J Neurochem 68 1997 265 271
57. A.P. Weible, M.M. Oh, G. Lee, J.F. Disterhoft Galantamine facilitates acquisition of hippocampus-dependent trace eyeblink conditioning in aged rabbits Learn Mem 11 2004 108 115
58. C. Weiss, A.R. Preston, M.M. Oh, R.D. Schwarz, D. Welty, J.F. Disterhoft The M1 muscarinic agonist CI-1017 facilitates trace eyeblink conditioning in aging rabbits and increases the excitability of CA1 pyramidal neurons J Neurosci 20 2000 783 790
59. P.J. Whitehouse, D.L. Price, A.W. Clark, J.T. Coyle, M.R. DeLong Alzheimer disease evidence for selective loss of cholinergic neurons in the nucleus basalis Ann Neurol 10 1981 122 126
60. S. Wonnacott Presynaptic nicotinic ACh receptors Trends Neurosci 20 1997 92 98
61. D.S. Woodruff-Pak, R.W. Vogel, G.L. Wenk Galantamine Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning Proc Natl Acad Sci USA 98 2001 2089 2094
62. M.R. Zamani, Y.S. Allen Nicotine and its interaction with β-amyloid protein a short review Biol Psychiatry 49 2001 221 232
63. L. Zhang, F.M. Zhou, J.A. Dani Cholinergic drugs for Alzheimer's disease enhance in vitro dopamine release Mol Pharmacol 66 2004 538 544